A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
BackgroundThe recurrence rate of T3N0 rectal cancer after total mesorectal excision (TME) is relatively low, meaning that not all patients need adjuvant therapy (AT) (radiotherapy, chemotherapy, or chemoradiotherapy).MethodsPatients diagnosed with pT3N0M0 rectal cancer after TME were analyzed using...
Guardado en:
Autores principales: | Chao Zhang, Shutao Zhao, Xudong Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b09db2ccdab544f7aacd918f7ba68b14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Results and Outcomes of Rectal Cancer Treatment in the Era of Adjuvant Chemoradiation
por: Ahmad Izadpanah, et al.
Publicado: (2019) -
Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
por: Silin Chen, et al.
Publicado: (2021) -
Evaluation of the learning curve of transanal total mesorectal excision: single-centre experience
por: Mateusz Rubinkiewicz, et al.
Publicado: (2019) -
Comparison of transanal versus laparoscopic total mesorectal excision in low rectal cancer
por: Seyed Vahid Hosseini, et al.
Publicado: (2020) -
Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
por: Yan J, et al.
Publicado: (2021)